
New CEO will lead medical school’s clinical practice
Executive arrives at a time of major growth in Yale’s practice, and change in American medicine as a whole
Paul Taheri, M.D., M.B.A., has joined the School of Medicine as deputy dean and chief executive officer of Yale Medical Group (YMG), following a nationwide search. Taheri began his new role at Yale in early March.Taheri was the senior associate dean for clinical affairs and president and CEO of the University of Vermont (UVM) Medical Group in Burlington as well as a professor of surgery at UVM. There, he was responsible for overseeing and managing a 500-member multispecialty practice with more...
Yale Cancer Center benefits doubly from generosity

United Technologies Corporation (UTC), a Hartford-based multinational manufacturer and Connecticut’s largest private...
Easing suffering, giving support at the end of life

The Palliative Care Program at Yale Cancer Center (YCC) has received a $1 million gift from the Milbank Foundation for...

Mapmakers of the living human body
Positron emission tomography is a vital tool for School of Medicine researchers studying psychiatric diseases, diabetes, and cancer
Spine Center lets patients in pain get back on track
Susan Cusano and Nina Kadan-Lottick, M.D., share an unhappy distinction: Far too early, they felt like frail, elderly...
Stem cells reveal a long-hidden mosaic
Although the many cells in a human body have distinct functions and appearances, it’s generally been assumed that they...
Women’s Health Research at Yale celebrates 15 years of success
Women’s Health Research at Yale (WHRY), whose mission is to ensure that women are included in research studies, gender...

Getting to the heart of disease
Scientist works toward molecular therapies for cardiovascular diseases





















